Otolaryngology Doctors in Purchase, NY Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Irene Yu, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3020 Westchester Ave Ste 303, Purchase, NY 10577 Phone: 914-253-8070

Dr. Jeffrey H Jablon, M.D. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3020 Westchester Ave, Suite 303, Purchase, NY 10577 Phone: 914-253-8070    Fax: 914-251-0868

Alexis Hope Jackman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3020 Westchester Avenue - Suite 303, Ent And Allergy Associates Llp, Purchase, NY 10577 Phone: 914-607-6501    Fax: 914-251-0868

Dr. Paul David Gittelman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3020 Westchester Ave, Suite 303, Purchase, NY 10577 Phone: 914-607-6501

Dr. David B Lawrence, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3020 Westchester Ave, Suite 303 - Enta, Purchase, NY 10577 Phone: 914-253-8070    Fax: 914-251-0868

News Archive

Study finds possible link between Type 2 diabetes and common white pigment

In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide - the most common white pigment in everyday products ranging from paint to candies - were found in pancreas specimens with Type 2 diabetes, suggesting that exposure to the white pigment is associated with the disease.

Study opens door to possible treatments for variety of mitochondrial diseases

By borrowing a tool from bacteria that infect plants, scientists have developed a new approach to eliminate mutated DNA inside mitochondria-the energy factories within cells. Doctors might someday use the approach to treat a variety of mitochondrial diseases, including the degenerative eye disease Leber hereditary optic neuropathy. The research, published online today in Nature Medicine, was funded by the National Eye Institute, a part of the National Institutes of Health.

St. Jude Medical gets European CE Mark approval for deep brain stimulation systems

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its Brio, Libra and LibraXP deep brain stimulation systems for managing the symptoms of intractable primary and secondary dystonia, a neurological movement disorder that causes a person's muscles to contract and involuntarily spasm, reducing the ability to control movement.

Syndax announces data from entinostat phase 2 study on HL

Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.

Read more Medical News

› Verified 6 days ago